Medtronic MiniMed Insulin Pump Recall - Paradigm Veo Z-1752-2026

Medtronic MiniMed, Inc. initiated a Class II medical device recall affecting Paradigm REAL-Time Veo Insulin Pumps (MMT-554, MMT-754) and all Paradigm series, 600 series, and BLE 700 series infusion pumps. The recall addresses a defect where gravitational force changes when the pump is elevated or lowered relative to the infusion site cause unintended over- and under-delivery of insulin, posing moderate-severity health risks to diabetic patients.\n\nHealthcare providers and patients managing diabetes should immediately identify any affected Medtronic MiniMed insulin pump models in use and coordinate with the manufacturer for replacement or correction options. Medtronic must implement the recall per FDA Class II procedures and notify affected parties of the insulin delivery malfunction and associated health risks.